返回 
加入收藏
基于CiteSpace可视化分析复发高级别胶质瘤的治疗研究现状
x
请在关注微信后，向客服人员索取文件
| 篇名： | 基于CiteSpace可视化分析复发高级别胶质瘤的治疗研究现状 |
| TITLE： | Visualization analysis of the therapy of recurrent high-grade gliomas based on CiteSpace |
| 摘要： | 目的 分析复发高级别胶质瘤的治疗领域热点、进展和前沿，为该领域研究提供参考。方法检索2005年1月1日－2022年3月14日WebofScience和中国知网数据库中的相关文献，使用CiteSpace6.1.R3软件分别对纳入文献的国家、作者、机构、关键词等进行计量分析，生成可视化网络图谱和数据。结果共纳入1019篇英文文献，308篇中文文献。国际发文量保持增长，国内发文量平稳。机构和作者之间合作较丰富。美国的中心性大（0.38），发文量最多（442篇），主要研究机构有加州大学洛杉矶分校、德州大学MD安德森癌症中心、丹娜-法伯癌症研究所等，重要的研究者有Wen、Cloughesy、Reardon等。国内研究团队相对固定、封闭。国际上，肿瘤发生机制和耐药机制是基础研究的重点，我国研究较少。放疗、化疗、靶向治疗、联合治疗是国际上研究较多的治疗方法，免疫治疗、光动力治疗是近几年新兴的疗法。我国对替莫唑胺和放疗研究较多。结论国际对治疗复发高级别胶质瘤的关注和投入在不断加大，美国在该领域具有极高影响力。目前放疗、传统化疗和贝伐珠单抗仍是复发高级别胶质瘤的主要治疗方式；免疫治疗、光动力治疗等新兴治疗方法有待更多尝试和研究。 |
| ABSTRACT： | OBJECTIVE To analyze the hotspots， progress and frontiers of the therapy of recurrent high-grade gliomas， and to provide a reference for the research in this field. METHODS The relevant literature were retrieved from the Web of Science and CNKI during Jan. 1st， 2005-Mar. 14th， 2022. CiteSpace 6.1.R3 software was used to quantitatively analyze the countries， authors， institutions and keywords of the included literature to form visual network maps and generate data. RESULTS A total of 1 019 English papers and 308 Chinese papers were included. The number of international publications kept growing and the number of domestic publications remained stable. Institutions and authors cooperated extensively. The United States featured a large centrality （0.38） and the largest number of publications （442）， with major research institutions such as the University of California San Francisco， University Texas MD Anderson Cancer Center， Dana-Farber Cancer Institute， and important researchers such as Wen， Cloughesy， Reardon， and so on. Domestic research groups were relatively fixed and closed. Internationally， the mechanism of tumorigenesis and drug resistance were the focus of basic research， while there was less basic research in China. Radiotherapy， chemotherapy， targeted therapy and combination therapy were studied the most internationally. Immunotherapy and photodynamic therapy were emerging therapies in recent years. In China， temozolomide and radiotherapy were the main research directions. CONCLUSIONS International attention and investment in the treatment of recurrent high-grade glioma are increasing. The United States has a high influence in this field. Currently， radiotherapy， traditional chemotherapeutic agents and bevacizumab are still the main treatment for recurrent high-grade glioma. Novel therapeutic approaches， including immunotherapy and photodynamic therapy， warrant more attempts and research. |
| 期刊： | 2023年第34卷第19期 |
| 作者： | 徐雅楠；季楠；赵志刚 |
| AUTHORS： | XU Yanan，JI Nan，ZHAO Zhigang |
| 关键字： | 高级别胶质瘤；复发；治疗；CiteSpace；可视化分析 |
| KEYWORDS： | high-grade glioma； recurrence； therapy； CiteSpace； visualization analysis |
| 阅读数： | 44 次 |
| 本月下载数： | 6 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
